Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G E Raskob

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Journal of Thrombosis and Haemostasis : JTH|March 7, 2014
Comparison of idrabiotaparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: the Borealis-Atrial Fibrillation StudyH R Buller, J Halperin, G J Hankey, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|May 1, 1998
Different effects of heparin in males and femalesN R Campbell, R D Hull, R Brant, et al.
Archives of Internal Medicine|April 22, 1996
Aging and heparin-related bleedingN R Campbell, R D Hull, R Brant, et al.
Archives of Internal Medicine|February 2, 1999
Preoperative vs postoperative initiation of low-molecular-weight heparin prophylaxis against venous thromboembolism in patients undergoing elective hip replacementR D Hull, R F Brant, G F Pineo, et al.
Annals of Internal Medicine|December 29, 1998
Drug-induced thrombocytopenia: a systematic review of published case reportsJ N George, G E Raskob, S R Shah, et al.
The Journal of Bone and Joint Surgery. British Volume|February 11, 2012
Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trialsG E Raskob, A S Gallus, G F Pineo, et al.
Archives of Internal Medicine|February 14, 1994
A noninvasive strategy for the treatment of patients with suspected pulmonary embolismR D Hull, G E Raskob, J S Ginsberg, et al.
Journal of Thrombosis and Haemostasis : JTH|January 3, 2013
Apixaban after hip or knee arthroplasty versus enoxaparin: efficacy and safety in key clinical subgroupsG F Pineo, A S Gallus, G E Raskob, et al.
Archives of Internal Medicine|April 1, 1988
Pulmonary embolism in outpatients with pleuritic chest painR D Hull, G E Raskob, C J Carter, et al.
Journal of Thrombosis and Haemostasis : JTH|September 27, 2015
Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trialG Agnelli, H R Buller, A Cohen, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Journal of Thrombosis and Haemostasis : JTH|March 7, 2014
Comparison of idrabiotaparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: the Borealis-Atrial Fibrillation StudyH R Buller, J Halperin, G J Hankey, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|May 1, 1998
Different effects of heparin in males and femalesN R Campbell, R D Hull, R Brant, et al.
Archives of Internal Medicine|April 22, 1996
Aging and heparin-related bleedingN R Campbell, R D Hull, R Brant, et al.
Archives of Internal Medicine|February 2, 1999
Preoperative vs postoperative initiation of low-molecular-weight heparin prophylaxis against venous thromboembolism in patients undergoing elective hip replacementR D Hull, R F Brant, G F Pineo, et al.
Annals of Internal Medicine|December 29, 1998
Drug-induced thrombocytopenia: a systematic review of published case reportsJ N George, G E Raskob, S R Shah, et al.
The Journal of Bone and Joint Surgery. British Volume|February 11, 2012
Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trialsG E Raskob, A S Gallus, G F Pineo, et al.
Archives of Internal Medicine|February 14, 1994
A noninvasive strategy for the treatment of patients with suspected pulmonary embolismR D Hull, G E Raskob, J S Ginsberg, et al.
Journal of Thrombosis and Haemostasis : JTH|January 3, 2013
Apixaban after hip or knee arthroplasty versus enoxaparin: efficacy and safety in key clinical subgroupsG F Pineo, A S Gallus, G E Raskob, et al.
Archives of Internal Medicine|April 1, 1988
Pulmonary embolism in outpatients with pleuritic chest painR D Hull, G E Raskob, C J Carter, et al.
Journal of Thrombosis and Haemostasis : JTH|September 27, 2015
Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trialG Agnelli, H R Buller, A Cohen, et al.
Pageof 8